The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats

DOI Web Site 被引用文献12件

書誌事項

公開日
2001-07-31
権利情報
  • https://www.cambridge.org/core/terms
DOI
  • 10.1017/s0033291701004056
公開者
Cambridge University Press (CUP)

この論文をさがす

説明

<jats:p><jats:bold>Background.</jats:bold> The clinician-administered version of the Liebowitz Social Anxiety Scale (LSAS-CA) is a commonly used assessment device for the evaluation of social anxiety disorder and has been shown to have strong psychometric characteristics. Because of its apparently straightforward rating format and potential savings in time and effort, interest in the use of the LSAS as a self-report (LSAS-SR) measure has increased, and the LSAS-SR has been used in a number of studies. However, the psychometric properties of the LSAS-SR have not been well established.</jats:p><jats:p><jats:bold>Methods.</jats:bold> This study examined the psychometric properties of the LSAS-SR in comparison to the LSAS-CA in a sample of 99 individuals with a primary diagnosis of social anxiety disorder and 53 individuals with no current psychiatric disorder.</jats:p><jats:p><jats:bold>Results.</jats:bold> There was little difference between the two versions of the LSAS on any scale or subscale score. Both forms were internally consistent and the subscale intercorrelations for the two forms were essentially identical. Correlations of each LSAS-SR index with its LSAS-CA counterpart were all highly significant. Finally, the convergent and discriminant validity of the two forms of the LSAS was shown to be strong.</jats:p><jats:p><jats:bold>Conclusion.</jats:bold> Results of this study suggest that the self-report version of the LSAS compares well to the clinician-administered version and may be validly employed in the assessment of social anxiety disorder.</jats:p>

収録刊行物

  • Psychological Medicine

    Psychological Medicine 31 (6), 1025-1035, 2001-07-31

    Cambridge University Press (CUP)

被引用文献 (12)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ